ClinicalTrials.Veeva

Menu

ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug Effects

S

Shamir Medical Center (Assaf-Harofeh)

Status

Unknown

Conditions

Diabetes Mellitus Type 2

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Proteinuria is an expression of diabetic nephropaty in type 1 and type 2 patients. Hypertenshion treatment and decreasing urine protein excretion, slow down renal deterioration. Treating diabetic ,hypertensive patients with Angiotensin Converting Enzyme inhibitors (ACEi), Angiotensin receptor blockers (ARBs)is common practice. The aim of our work is to examine 1.The prevalence of ACE and ARB treatment in diabetic patients with or without hypertension.2. Adverse drug reactions of ACEi and ARBs alone or in combination.

Full description

The study group- men and women with diabetes mellitus type 2,who were hospitalized in the department of internal medicine in Assaf- Harofeh Medical Center.

During hospitalization, data regarding the clinical history,chronic diseases and drugs were collected from the medical files. Blood tests results were recorded during hospitalization .The patients were asked about adverse drug effects.

Sex

All

Ages

40 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type 2 diabetic patients admitted to department of Internal Medicine in Assaf Harofeh Medical Center

Exclusion criteria

  • Type 1 diabetes mellitus

Trial contacts and locations

1

Loading...

Central trial contact

Alina Alperovich, B.Pharm; Gabby Elbaz, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems